Related Experiment Video
Updated: Apr 6, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Update on melanoma epigenetics
Blanca de Unamuno1, Sarai Palanca, Rafael Botella
1aDepartment of Dermatology bMolecular Biology Laboratory, Service of Clinical Analysis, University Hospital La Fe, Valencia, Spain.
Purpose Of Review:
Over the last years, our understanding in molecular biology of melanoma has grown significantly and many genetic alterations have been identified affecting melanoma pathogenesis. This growing evidence has led to the development of targeted therapies which are showing promising clinical results. In addition to genetic alterations, an increasing number of studies have recently demonstrated the role of epigenetics in melanoma development and progression. Here, we summarize the current data on epigenetic research in melanoma.
Recent Findings:
MicroRNA (miRNA) expression profiling studies have identified several miRNAs implicated in melanoma cell cycle and proliferation, cell migration and invasion, as well as miRNAs involved in apoptosis and immune response. Abnormal methylation profiling has been associated with melanoma progression and to date aberrant hypermethylation in more than 70 genes has been described. Recent works have highlighted the increasing evidence of the role of histone modification as a central regulatory event in melanoma pathogenesis.
Summary:
Many of these epigenetic biomarkers may have potential diagnostic, prognostic and therapeutic implications. Future approach might be using a combination of genetic and epigenetic biomarkers.
Insights
Epigenetics, including microRNA expression and DNA methylation, plays a crucial role in melanoma development and progression. These epigenetic biomarkers offer potential for diagnosing, predicting, and treating melanoma.
Area of Science:
- Molecular biology
- Cancer research
- Genetics
Background:
- Melanoma pathogenesis is increasingly understood through molecular biology, with identified genetic alterations driving targeted therapy development.
- Epigenetic factors, beyond genetic mutations, are recognized for their significant role in melanoma development and progression.
Purpose of the Study:
- To review current data on epigenetic research in melanoma.
- To highlight the implications of epigenetic alterations in melanoma.
Main Methods:
- Review of microRNA (miRNA) expression profiling studies.
- Analysis of DNA methylation profiling data.
- Examination of histone modification research in melanoma.
Main Results:
- miRNA expression profiling identified miRNAs regulating cell cycle, proliferation, migration, invasion, apoptosis, and immune response in melanoma.
- Abnormal DNA methylation is linked to melanoma progression, with over 70 genes showing aberrant hypermethylation.
- Histone modifications are increasingly recognized as central regulatory events in melanoma pathogenesis.
Conclusions:
- Epigenetic biomarkers hold potential for diagnostic, prognostic, and therapeutic applications in melanoma.
- Future melanoma treatment strategies may involve combining genetic and epigenetic biomarkers.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Renewal of Skin Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

